Prothena Biosciences (NASDAQ:PRTA) Engages FLG Partners

“FLG Partners provided seasoned talent in Laureen DeBuono, as Interim CFO for over two years, to help scale Rodan+Field’s business, both operationally and strategically from $300M in net revenues in 2014 to $1.2B in 2016. What they delivered speaks for itself; a 5 year strategic plan including an annual operating plan, a new finance team, a renegotiated $200M line of credit and exit scenarios and strategies for the company. We would recommend FLG to any company looking for top-tier financial expertise and advice when scaling for explosive growth.”